Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Baxter
Healthtrust
Fuji
McKinsey
Chubb

Generated: September 19, 2019

DrugPatentWatch Database Preview

Ibuprofen lysine - Generic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

What are the generic sources for ibuprofen lysine and what is the scope of ibuprofen lysine freedom to operate?

Ibuprofen lysine is the generic ingredient in two branded drugs marketed by X-gen Pharms Inc and Recordati Rare, and is included in two NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ibuprofen lysine has twelve patent family members in six countries.

There are sixty-four drug master file entries for ibuprofen lysine. Three suppliers are listed for this compound.

Summary for ibuprofen lysine
Pharmacology for ibuprofen lysine
Synonyms for ibuprofen lysine
(+/-)-(S)-p-Isobutylhydratropic acid, compound with L-lysine (1:1)
(|AS)-|A-Methyl-4-(2-methylpropyl)benzeneacetic Acid L-Lysine
(2s)-2-(4-isobutylphenyl)propanoic acid - l-lysine hydrate (1:1:1)
(2S)-2,6-bis(azanyl)hexanoic acid; 2-[4-(2-methylpropyl)phenyl]propanoic acid
(2S)-2,6-diaminohexanoic acid,2-[4-(2-methylpropyl)phenyl]propanoic acid
(2S)-2,6-diaminohexanoic acid; 2-(4-isobutylphenyl)propanoic acid
(2S)-2,6-diaminohexanoic acid; 2-[4-(2-methylpropyl)phenyl]propanoic acid
(S)-(+)-Ibuprofen (S)-(+)-Lysinate
(S)-2,6-Diaminohexanoic acid compound with 2-(4-isobutylphenyl)propanoic acid (1:1)
(S)-ibuprofen (S)-lysine
113403-10-4
127701-63-7
2,6-diaminohexanoic acid,2-[4-(2-methylpropyl)phenyl]propanoic acid
2,6-diaminohexanoic acid; 2-(4-isobutylphenyl)propanoic acid
469I779
57469-76-8
57469-77-9
82240-06-0
A831448
AB01274868_02
AB01274868-01
AB2000139
ABP000512
AC-19865
AKOS015963349
AKOS015994629
AN-39982
AN-39983
API0010415
Arflamin
B5VWM9PYNC
BC215814
BCP9000769
Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (S)-, compd. with L-lysine (1:1)
CHEMBL1201141
CTK8F2111
D06606
Dexibuprofen lysine anhydrous
DTXSID50432054
DTXSID70150405
FT-0670262
HS-0089
Ibuprofen L-lysine (JAN)
Ibuprofen lysinate
Ibuprofen Lysine (NeoProfen)
Ibuprofen lysine (USAN)
Ibuprofen lysine [USAN]
Ibuprofen lysine/
IHHXIUAEPKVVII-PTKYJSHISA-N
KS-00002WUK
L-lysine compound with 2-(4-isobutylphenyl)propanoic acid (1:1)
L-lysine; ibuprofen
MolPort-006-131-242
Neoprofen
Neoprofen (TN)
S(+)-Ibuprofen L-Lysine
s1518
SC-16390
SCHEMBL44616
SCHEMBL44617
SCHEMBL8733957
Solufenum
UNII-B5VWM9PYNC
UNII-N01ORX9D6S component IHHXIUAEPKVVII-PTKYJSHISA-N

US Patents and Regulatory Information for ibuprofen lysine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare NEOPROFEN ibuprofen lysine INJECTABLE;INTRAVENOUS 021903-001 Apr 13, 2006 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
X-gen Pharms Inc IBUPROFEN LYSINE ibuprofen lysine INJECTABLE;INTRAVENOUS 202402-001 Mar 30, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare NEOPROFEN ibuprofen lysine INJECTABLE;INTRAVENOUS 021903-001 Apr 13, 2006 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y Y ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Harvard Business School
Deloitte
QuintilesIMS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.